Clinical Trial Update: Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Equetro (carbamazepine extended-release) for mania in children aged 6-12 with bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Mania

Drugs mentioned

• EQUETRO (CARBAMAZEPINE)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Bipolar Disorder, Mania | Phase 4 | Status: COMPLETED